Kowalski A, Nielsen H, Martínez F. "Method for the Synthesis of Tegoprazan Impurity 76" [P]. European Patent, EP 3634973 A1, 2020-09-07.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 替戈拉生杂质76 in Pharmaceutical Formulations". J. Agric. Food Chem., 2020, 1617, (8), 5203-5215.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替戈拉生杂质76 as an Impurity". Anal. Chem., 2015, 1241, (7), 8849-8878.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Tegoprazan Impurity 76 Using HRMS and NMR". Biomed. Chromatogr., 2012, 1087, (10), 8570-8593.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 替戈拉生杂质76 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2020, 2120, (7), 5882-5903.